NEUROENDOCRINE BREAST TUMOUR

NEUROENDOCRINE BREAST TUMOUR was reported 18 times

NEUROENDOCRINE BREAST TUMOUR is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Aromatase Inhibitor [EPC] 7 0.0001
1 Microtubule Inhibitor [EPC] 7 0.0000
2 Topoisomerase Inhibitor [EPC] 3 0.0000
3 Estrogen Receptor Antagonist [EPC] 1 0.0000
4 Nucleoside Metabolic Inhibitor [EPC] 6 0.0000
5 Platinum-based Drug [EPC] 3 0.0000
6 Kinase Inhibitor [EPC] 6 0.0000
7 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
8 Progestin [EPC] 1 0.0000